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EDITORIAL
Folliculogenesis and oogenesis: from
basic science to the clinic
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1Centre for Reproductive Biology, University of Edinburgh College of Medicine and Veterinary Medicine, Chancellor’s Building, 47 Little
France Crescent, Edinburgh EH16 4TJ, UK
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3University Bielefeld, Faculty of Biology, Gene Technology/Microbiology, D-33501 Bielefeld, Germany
From germ cell to fertilizable oocyte is a journey that captures the
essence of MHR: a quest to understand the basic science of reproduc-
tive medicine. In view of the rapid developments in molecular biology
and genetics, a major goal of ESHRE in recent years has been to
provide clinicians, counsellors, embryologists and the public with
novel research ﬁndings of relevance to assisted reproduction technol-
ogies (ART). In this spirit, the ESHRE Campus workshop in Potsdam in
October 2009 on ‘Mammalian Folliculogenesis and Oogenesis: from
basic science to the clinic’ was dedicated to fundamental research in
an area that is increasingly affecting clinical practice. The meeting
was well attended (Fig. 1) and eight invited speakers submitted manu-
scripts for peer review and collation into this thematic issue of MHR,
the key messages of which are highlighted below.
Møllga˚rd et al. (2010) open with a novel perspective on how human
primordial germ cells (PGCs) ﬁrst visible in the wall of the embryonic
yolk sac might migrate to the hindgut and the primitive gonads. On the
basis of an elegant series of immunocytochemical and electron micro-
scopic observations, they posit that a majority of PGCs remain at the
proximal end of the yolk sac, which becomes part of the wall of the
hind- and midgut close to where the gonads develop. PGCs do not
therefore have to move very far in order to reach the gonadal
ridges. The idea is that PGCs migrate from there to the primitive
gonad by tracking autonomic nerve ﬁbres and Schwann cells extending
across the dorsal mesentery to the gonadal ridge. The invoked path-
ﬁnder function of these cells might be explained by their release of
chemo-attractants and/or transmit survival signals that may support
and guide PGC migration from the hindgut to the gonads.
De Felici (2010) revisits the controversial issue of mammalian
neo-oogenesis, speculating how germ stem cells (GSCs) found in
the ovary after birth might be derived from somatic cells, PGCs
or PGC-derived GSCs formed before birth. Such cells that
commence—but do not complete—programming into germ cells
during early embryogenesis may be retained into adulthood, providing
precursors for ‘neo-oogenesis’ under certain (e.g. stress-related)
conditions later on. However, as De Felici (2010) concedes, crucial
evidence for the progression of such stem cells to fully competent
oocytes in an adult ovary is absent. Moreover, there is still no com-
pelling evidence that neo-oogenesis occurs naturally or is inducible
in mammals.
Turning to the initiation of follicular growth, Nielsen et al.
(2010) spotlight the TGF-beta superfamily member Anti-Mullerian
Hormone (AMH), which is produced by follicular epithelial (granulosa)
cells. They report that AMH concentration in follicular ﬂuid and gran-
ulosa cell mRNA expression of CYP19 (encoding the aromatase
enzyme essential for estrogen synthesis) are negatively correlated in
human small antral follicles, consistent with a suppressive paracrine
effect of AMH on follicular development. However, since AMH recep-
tor2 (AMH-r2), follicle-stimulating hormone receptor 2 (FSH-r) and
CYP19 mRNA are all positively associated, the role of AMH in follicu-
lar development and steroidogenesis remains enigmatic.
Folliculogenesis is a protracted process in humans requiring several
months from primordial follicle recruitment to large antral follicle for-
mation and ovulation. Activin, another member of the TGF-beta family
of growth factors produced by granulosa cells, is known to modulate
FSH action during pre-antral follicle development. McLaughlin et al.
(2010) investigate the interaction of activin and FSH on bovine cul-
tured pre-antral follicles as a model for humans. They provide evi-
dence that activin treatment alone or with FSH promotes oocyte
growth, through increasing connexin 43 gap junctional expression in
a polarized fashion (i.e. at the oocyte/granulosa cell interface and at
the follicular periphery); thereby activin supports granulosa cell ancho-
rage to the follicle wall (basement membrane) as well as the zona pel-
lucida of the oocyte. This previously unknown property of activin
could have translational implications for the improvement of clinical
in vitro maturation culture protocols.
The ﬁnal step in follicular maturation leading to release of a fertiliz-
able oocyte depends on the ovulation-inducing Luteinising Hormone
(LH) surge. The mini-review by Solc et al. (2010) surveys the signalling
pathways through which LH triggers meiotic resumption. These
involve paracrine signalling via epidermal growth factor (EGF)-like pro-
teins produced in mural granulosa cells should lead to reduced cGMP
formation in cumulus cells. Since cGMP inactivates phosphodiesterase
3a (PDE3a) in the oocyte the reduction in cGMP in turn causes PDE3a
activation and cAMP decrease. The attendant cAMP decrease orches-
trates the downstream signalling network that switches on the CDK1/
CyclinB (MPF) ‘master switch’, to resume meiosis.
Vogt et al. (2010) focus on the M-phase to anaphase I transition
during meiotic maturation. Their work emphasizes Aurora kinase B
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and the mitotic centromere-associated kinesin (MCAK), which is a
microtubule depolymerase that affects chromosome behaviour and
corrects microtubule attachment during mitosis. Prompted by the evi-
dence that oocytic abundance of both mRNAs alters with aging, they
analyse the distribution and possible function of MCAK in maturing
mouse oocytes. They report MCAK protein enrichment at centro-
meres and centrosomes at the spindle poles and presence of the
protein at the central spindle and in the midbody, as assessed by
immunocytochemistry and overexpression of a MCAK-EGFP fusion
protein. This pattern of distribution resembles that seen in somatic
cells. However, MCAK is also enriched in multiple centrosomes at
acentriolar spindle poles and at centromeres of homologous chromo-
somes at prometaphase and metaphase I oocytes, consistent with a
unique meiotic function of MCAK, possibly through modulating micro-
tubule dynamics and preventing precocious chiasma resolution. The
take-home message here is that alterations in MCAK abundance or
activity such as in ageing oocytes may contribute to errors in chromo-
some segregation and aneuploidy.
Attention then switches to telomere dynamics in oogenesis and
embryogenesis. Building on evidence that short telomeres are
associated with infertility in mice, Turner et al. (2010) use quantitative
ﬂuorescence microscopy to analyse telomeres in nuclei of human
GV-stage oocytes up to cleavage stage embryos, and blastocysts.
Their data imply that telomeres shorten in length during the
GV-to-cleavage stage of oogensis. However, telomere length
appears to vary greatly within blastomeres of an individual embryo
and within patient groups, and there are dynamic, stage-speciﬁc
changes in telomere length according to the stage of preimplantation
development. More research is clearly warranted to determine if
this level of control meaningfully impacts the clinical outcome.
Finally, two papers consider oocyte and embryo ‘quality’ in relation
to genome stability and epigenesis. Li (2010) reviews evidence that a
maternal zygotic effect gene coding for a zinc-ﬁnger protein (ZFP57) is
involved in stabilization of differential DNA methylation marks at
imprinted regions of many mammalian genes. Unlike the reported
knockouts of other maternal effect genes, there is an unexpectedly
late (mid-gestation) embryonic lethal phenotype in the ZFP57 knock-
out, possibly due to accumulated imprint defects during early preim-
plantation development. Thus oocyte-derived factors can affect
epigenetic events in embryos, and mutations or epimutations during
Figure 1 (A) Some of the participants at the visit to castle Sanssouci.
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oogenesis may have potentially damaging consequences for embryonic
development and ‘wellbeing’.
Concerns persist that hormonal stimulation or handling and culture
of oocytes and embryos might be responsible for epigenetic abnorm-
alities in the children conceived by ART. Zechner et al. (2010)
describe the methylation patterns at differentially methylated regions
of a number of imprinted genes as well as in promoter regions of a
pluripotency and a tumour suppressor gene in chorionic villus
samples of spontaneous miscarriages or stillbirths obtained after
ART or spontaneous conception. Unexpectedly, rates of extreme
methylation values and epigenetic imprinting defects, which might
cause reprogramming defects, were lower in the villi of samples
from ART cycles compared with the spontaneous conception cases.
Furthermore, there was no evidence for differences in methylation
patterns between ICSI and IVF-derived cases. These data reinforce
other evidence that ART techniques per se do not increase imprint
errors. However, it remains likely that methylation abnormalties con-
tribute to characteristically high rates of human pregnancy loss,
whether conception be natural or clinically contrived.
Overall this thematic MHR issue testiﬁes to the importance of
development/cell/pathway biology approaches to understanding
female gametogenesis and gonadal formation, and how they might
translate to reproductive health. We hope readers enjoy the papers
and sense the spirit of the workshop, which truly captured the rel-
evance of basic research to the clinical practice of reproductive
medicine.
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